Keywords
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Keywords » - entrée « Antimalarials (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antimalarials (administration & dosage) < Antimalarials (adverse effects) < Antimalarials (blood)  Facettes :

List of bibliographic references indexed by Antimalarials (adverse effects)

Number of relevant bibliographic references: 58.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000042 (2021) Amaya García-Fernández [Espagne] ; Pablo Ramos-Ruiz [Espagne] ; Alicia Ibá Ez-Criado [Espagne] ; Scar Moreno-Pérez [Espagne] ; Cristina Cambra-Poveda [Espagne] ; Juan Gabriel Martínez-Martínez [Espagne]Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.
000045 (2021) Mudit Agarwal [Inde] ; Piyush Ranjan [Inde] ; Ankit Mittal [Inde] ; Upendra Baitha [Inde]Use of hydroxychloroquine for pre-exposure prophylaxis in COVID 19: debate and suggested future course.
000070 (2021) Bagrat Lalabekyan [Royaume-Uni] ; Gudrun Kunst [Royaume-Uni] ; Vanessa A. Skelton [Royaume-Uni]Torsades de Pointes in Coronavirus Disease 2019 Infection.
000099 (2021) Zelyn Lee [Canada] ; Craig R. Rayner [États-Unis, Australie] ; Jamie I. Forrest [Canada] ; Jean B. Nachega [Afrique du Sud, États-Unis, Canada] ; Esha Senchaudhuri [Canada] ; Edward J. Mills [Canada]The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19.
000175 (2021) Okechukwu S. Ogah [Nigeria] ; Ejiroghene M. Umuerri ; Adewole Adebiyi [Nigeria] ; Olanike A. Orimolade [Nigeria] ; Mahmoud U. Sani ; Dike B. Ojji ; Amam C. Mbakwem ; Simon Stewart ; Karen SliwaSARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications.
000382 (2021) Michael Malaty [Australie] ; Tahrima Kayes [Australie] ; Anjalee T. Amarasekera [Australie] ; Matthew Kodsi [Australie] ; C Raina Macintyre [Australie] ; Timothy C. Tan [Australie]Incidence and treatment of arrhythmias secondary to coronavirus infection in humans: A systematic review.
000391 (2021) Yufeng Shang [République populaire de Chine] ; Tao Liu [République populaire de Chine] ; Jingfeng Li [République populaire de Chine] ; Natasha Mupeta Kaweme [République populaire de Chine] ; Xinghuan Wang [République populaire de Chine] ; Fuling Zhou [République populaire de Chine]Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus.
000467 (2021) Elena Beyzarov [États-Unis] ; Yan Chen [États-Unis] ; Rob Julg [États-Unis] ; Karen Naim [États-Unis] ; Jigna Shah [États-Unis] ; William W. Gregory [États-Unis] ; Ayman Ayoub [États-Unis] ; Patrick Caubel [États-Unis]Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor's Perspective.
000469 (2021) I. Abadías-Granado [Espagne] ; A M Palma-Ruiz [Espagne] ; P A Cerro [Espagne] ; A M Morales-Callaghan [Espagne] ; M C G Mez-Mateo [Espagne] ; Y. Gilaberte [Espagne] ; R A Schwartz [États-Unis]Generalized pustular figurate erythema first report in two COVID-19 patients on hydroxychloroquine.
000506 (2021) Barbara Burgos-Blasco [Espagne] ; Noemi Güemes-Villahoz [Espagne] ; Beatriz Vidal-Villegas [Espagne] ; Juan Donate-Lopez [Espagne] ; Julian Garcia-Feijoo [Espagne]Evaluation of retinotoxicity of COVID-19 treatment: Hydroxychloroquine and lopinavir/ritonavir.
000553 (2021) Daniel García-Rodríguez [Espagne] ; Paloma Remior [Espagne] ; Eusebio García-Izquierdo [Espagne] ; Jorge Toquero [Espagne] ; Víctor Castro [Espagne] ; Ignacio Fernández Lozano [Espagne]Drug-induced QT prolongation in COVID-19 pneumonia: influence on in-hospital survival.
000611 (2021) Mary Kelly [Irlande (pays)] ; R Isìn O'Connor [Irlande (pays)] ; Liam Townsend [Irlande (pays)] ; Miriam Coghlan [Irlande (pays)] ; Eileen Relihan [Irlande (pays)] ; Miriam Moriarty [Irlande (pays)] ; Bernard Carr [Irlande (pays)] ; Gail Melanophy [Irlande (pays)] ; Caitriona Doyle [Irlande (pays)] ; Ciaran Bannan [Irlande (pays)] ; Ruth O'Riordan [Irlande (pays)] ; Concepta Merry [Irlande (pays)] ; Susie Clarke [Irlande (pays)] ; Colm Bergin [Irlande (pays)]Clinical outcomes and adverse events in patients hospitalised with COVID-19, treated with off-label hydroxychloroquine and azithromycin.
000633 (2021) Bhagteshwar Singh [Royaume-Uni, Inde] ; Hannah Ryan [Royaume-Uni] ; Tamara Kredo [Afrique du Sud] ; Marty Chaplin [Royaume-Uni] ; Tom Fletcher [Royaume-Uni]Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
000653 (2021) Adam Goldman [Israël] ; David Bomze [Israël, Suisse] ; Rachel Dankner [Israël] ; Hanoch Hod [Israël] ; Tomer Meirson [Israël] ; Ben Boursi [Israël, États-Unis] ; Elad Maor [Israël]Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
000723 (2021) Andrea Bernardini [Italie] ; Giuseppe Ciconte [Italie] ; Gabriele Negro [Italie] ; Roberto Rondine [Italie] ; Valerio Mecarocci [Italie] ; Tommaso Viva [Italie] ; Francesca Santini [Italie] ; Carlo De Innocentiis [Italie] ; Luigi Giannelli [Italie] ; Ewa Witkowska [Italie] ; Emanuela Teresina Locati [Italie] ; Serenella Castelvecchio [Italie] ; Massimiliano M. Marrocco-Trischitta [Italie] ; Gabriele Vicedomini [Italie] ; Lorenzo Menicanti [Italie] ; Carlo Pappone [Italie]Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen.
000746 (2021) Andy On-Tik Wong [États-Unis] ; Bimal Gurung [Hong Kong] ; Wing Sum Wong [États-Unis] ; Suet Yee Mak [États-Unis] ; Wan Wai Tse [États-Unis] ; Chloe M. Li [Hong Kong] ; Deborah K. Lieu [États-Unis] ; Kevin D. Costa [États-Unis] ; Ronald A. Li [États-Unis] ; Roger J. Hajjar [États-Unis]Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues.
000766 (2021) Vakaramoko Diaby [États-Unis] ; Reem D. Almutairi [États-Unis] ; Ziyan Chen [États-Unis] ; Richard K. Moussa ; Abdrahmane Berthe [Canada]A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19.
000844 (2020) Anwar M. Hashem [Arabie saoudite] ; Badrah S. Alghamdi [Arabie saoudite] ; Abdullah A. Algaissi [Arabie saoudite] ; Fahad S. Alshehri [Arabie saoudite] ; Abdullah Bukhari [Arabie saoudite] ; Mohamed A. Alfaleh [Arabie saoudite] ; Ziad A. Memish [États-Unis]Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.
000848 (2020) Anuj Sharma [États-Unis]Chloroquine paradox may cause more damage than help fight COVID-19.
000856 (2020) Amit Malviya [Inde]Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
000862 (2020) Amit Dang [Inde] ; B N Vallish [Inde] ; Sumit Dang [États-Unis]Hydroxychloroquine and Remdesivir in COVID-19: A critical analysis of recent events.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antimalarials (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antimalarials (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antimalarials (adverse effects)
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021